Peshu N

Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.Bejon P, Mwangi T, Lowe B, Peshu N, Hill AV, Marsh K
Vaccine, (2007). 25:8198-202

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B, Lang T, Mwangi TW, Gilbert SC, Peshu N, Marsh K, Hill AV
J Immunol, (2007). 179:4193-201

Defining childhood severe falciparum malaria for intervention studies.Bejon P, Berkley JA, Mwangi T, Ogada E, Mwangi I, Maitland K, Williams T, Scott JA, English M, Lowe BS, Peshu N, Newton CR, Marsh K
PLoS Med, (2007). 4:e251

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Ogada E, Mwangi T, Milligan P, Lang T, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS One, (2007). 2:e707

Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.Khor CC, Vannberg FO, Chapman SJ, Walley A, Aucan C, Loke H, White NJ, Peto T, Khor LK, Kwiatkowski D, Day N, Scott A, Berkley JA, Marsh K, Peshu N, Maitland K, Williams TN, Hill AV
Genes Immun, (2007). 8:570-6

'Are you on the market?': a capture-recapture enumeration of men who sell sex to men in and around Mombasa, Kenya.Geibel S, van der Elst EM, King'ola N, Luchters S, Davies A, Getambu EM, Peshu N, Graham SM, McClelland RS, Sanders EJ
AIDS, (2007). 21:1349-54

Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J, Crawley J, Fegan G, Bauni E, Peshu N, Marsh K, Neville B, Newton C
JAMA, (2007). 297:2232-40

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV
Nat Genet, (2007). 39:523-8

Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.Ostrowski SR, Shulman CE, Peshu N, Staalsoe T, Hoyer-Hansen G, Pedersen BK, Marsh K, Ullum H
Parasite Immunol, (2007). 29:37-46

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS Clin Trials, (2006). 1:e29

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.Bejon P, Keating S, Mwacharo J, Kai OK, Dunachie S, Walther M, Berthoud T, Lang T, Epstein J, Carucci D, Moris P, Cohen J, Gilbert SC, Peshu N, Marsh K, Hill AV
Infect Immun, (2006). 74:6331-8

Implementation of a structured paediatric admission record for district hospitals in Kenya--results of a pilot study.Mwakyusa S, Wamae A, Wasunna A, Were F, Esamai F, Ogutu B, Muriithi A, Peshu N, English M
BMC Int Health Hum Rights, (2006). 6:9

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.Bejon P, Kai OK, Mwacharo J, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Eur J Immunol, (2006). 36:2264-72

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.Bejon P, Mwacharo J, Kai OK, Todryk S, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Vaccine, (2006). 24:4709-15

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, Lang T, Hill AV, Marsh K
Clin Infect Dis, (2006). 42:1102-10

Trust and informed consent: insights from community members on the Kenyan coast.Molyneux CS, Peshu N, Marsh K
Soc Sci Med, (2005). 61:1463-73

'Even if they ask you to stand by a tree all day, you will have to do it (laughter)...!': community voices on the notion and practice of informed consent for biomedical research in developing countries.Molyneux CS, Wassenaar DR, Peshu N, Marsh K
Soc Sci Med, (2005). 61:443-54

Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit.Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C, Levin M
Clin Infect Dis, (2005). 40:538-45

Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion.Maitland K, Pamba A, English M, Peshu N, Levin M, Marsh K, Newton CR
Br J Haematol, (2005). 128:393-400

Antibodies to voltage-gated calcium channels in children with falciparum malaria.Lang B, Newbold CI, Williams G, Peshu N, Marsh K, Newton CR
J Infect Dis, (2005). 191:117-21